Truncated HER2 in Blood Associated With Poor Outcome in Breast Cancer

Truncated HER2 in Blood Associated With Poor Outcome in Breast Cancer
The presence of the truncated form of human epidermal growth factor receptor 2 (p95HER2) in circulating tumor cells (CTCs) is associated with poor survival in breast cancer patients, according to a new study. These cells are detectable in both early …Read more on Cancer Network

Chemotherapy-Free Regimen Feasible for Acute Promyelocytic Leukemia
New research showed that it appears to be feasible to treat low- and high-risk patients with acute promyelocytic leukemia with the chemotherapy-free regimen of all-trans retinoic acid (ATRA) and arsenic trioxide. Results of the AML17 study, published …Read more on Cancer Network

Most Young Lung Cancers Patients Have Targetable Genes
Seventy-five percent of patients diagnosed with metastatic adenocarcinoma of the lung before age 40 have an actionable mutation, according to preliminary results from the Genomics of Young Lung Cancer Study (NCT02273336), the first prospective study of …Read more on Cancer Network